A similar phenomenon has recently been reported in VHL‐deficient clear cell renal cell carcinoma where PHD3 silencing downregulated HIF‐2α mRNA stability (Miikkulainen et al., 2019; Zacharias et al., 2021). This evidence concerns the gene EGLN3 and clear cell renal carcinoma.